Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immunoglobulin Light-chain Amyloidosis × fludarabine phosphate × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 50 Precursor Cell Lymphoblastic Leukemia-Lymphoma 41 Myelodysplastic Syndromes 37 Leukemia, Lymphocytic, Chronic, B-Cell 27 Lymphoma, Non-Hodgkin 25 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18 Multiple Myeloma 16 Leukemia 16 Hodgkin Disease 16 Lymphoma, Follicular 15 Leukemia, Biphenotypic, Acute 14 Lymphoma, Large B-Cell, Diffuse 13 Leukemia, Myelomonocytic, Chronic 13 Hematologic Neoplasms 13 Myeloproliferative Disorders 12 Melanoma 12 Lymphoma, Mantle-Cell 12 Lymphoma 12 Anemia, Refractory, with Excess of Blasts 12 Lymphoma, B-Cell 11 Burkitt Lymphoma 11 Recurrence 10 Lymphoma, B-Cell, Marginal Zone 9 Primary Myelofibrosis 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Neoplasms 6 Neuroblastoma 5 Neoplasm, Residual 5 Neoplasm Metastasis 5 Leukemia, Myeloid, Accelerated Phase 5

Interventions

Dexamethasone 11 daratumumab 6 Bortezomib 6 Cyclophosphamide 5 venetoclax 3 ixazomib 3 belantamab mafodotin 3 Specimen Handling 3 Focal Adhesion Protein-Tyrosine Kinases 3 Calcium Dobesilate 3 pomalidomide 2 dexamethasone acetate 2 dexamethasone 21-phosphate 2 auricularum 2 X-Rays 2 Polymerase Chain Reaction 2 Phantoms, Imaging 2 Magnetic Resonance Spectroscopy 2 Clinical Protocols 2 Biopsy 2 4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 2 siltuximab 1 isatuximab 1 Valganciclovir 1 Therapeutics 1 Stem Cell Transplantation 1 Spectrometry, Fluorescence 1 Positron-Emission Tomography 1 Pharmaceutical Preparations 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡